Eaton Vance Management continued to hold its stake in HealthEquity Inc. (NASDAQ:HQY) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,032 shares of the company’s stock at the end of the second quarter. Eaton Vance Management’s holdings in HealthEquity were worth $761,000 as of its most recent SEC filing.
Other large investors also recently added to or reduced their stakes in the company. Norges Bank bought a new stake in HealthEquity during the fourth quarter worth about $10,277,000. Royce & Associates LP purchased a new position in shares of HealthEquity during the second quarter worth $5,226,000. Hood River Capital Management LLC raised its position in shares of HealthEquity by 165.1% in the second quarter. Hood River Capital Management LLC now owns 254,750 shares of the company’s stock worth $7,741,000 after buying an additional 158,650 shares during the last quarter. Bank of Montreal Can purchased a new position in shares of HealthEquity during the second quarter worth $3,295,000. Finally, Mckinley Capital Management LLC Delaware purchased a new position in shares of HealthEquity during the first quarter worth $2,658,000. 90.54% of the stock is currently owned by hedge funds and other institutional investors.
Shares of HealthEquity Inc. (NASDAQ:HQY) traded down 1.15% during mid-day trading on Wednesday, reaching $37.05. 205,922 shares of the company traded hands. The company’s 50 day moving average is $32.53 and its 200 day moving average is $28.23. The stock has a market capitalization of $2.17 billion, a price-to-earnings ratio of 95.00 and a beta of 1.65. HealthEquity Inc. has a 52-week low of $15.80 and a 52-week high of $37.96.
HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, September 6th. The company reported $0.16 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.13 by $0.03. The company had revenue of $44.20 million for the quarter. HealthEquity had a return on equity of 10.89% and a net margin of 15.21%. The firm’s revenue for the quarter was up 44.9% on a year-over-year basis. During the same period last year, the company posted $0.08 EPS. On average, equities analysts forecast that HealthEquity Inc. will post $0.51 earnings per share for the current year.
Several research analysts have recently commented on HQY shares. SunTrust Banks Inc. lifted their price target on HealthEquity from $34.00 to $40.00 and gave the stock a “buy” rating in a report on Wednesday, June 8th. Wells Fargo & Co. reiterated a “buy” rating on shares of HealthEquity in a report on Wednesday, June 8th. Leerink Swann reiterated an “outperform” rating and set a $33.00 price target (up previously from $30.00) on shares of HealthEquity in a report on Wednesday, June 8th. TheStreet upgraded HealthEquity from a “sell” rating to a “hold” rating in a report on Tuesday, June 7th. Finally, Zacks Investment Research upgraded HealthEquity from a “hold” rating to a “buy” rating and set a $32.00 price target on the stock in a report on Thursday, June 9th. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. HealthEquity presently has a consensus rating of “Buy” and a consensus target price of $36.00.
In related news, CFO Darcy G. Mott sold 10,000 shares of the stock in a transaction on Monday, August 22nd. The stock was sold at an average price of $29.13, for a total transaction of $291,300.00. Following the sale, the chief financial officer now owns 80,000 shares of the company’s stock, valued at $2,330,400. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Jon Kessler sold 54,712 shares of the stock in a transaction on Tuesday, September 20th. The shares were sold at an average price of $35.07, for a total value of $1,918,749.84. Following the sale, the chief executive officer now directly owns 485,288 shares in the company, valued at approximately $17,019,050.16. The disclosure for this sale can be found here. 29.00% of the stock is owned by company insiders.
HealthEquity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity Inc. (NASDAQ:HQY).
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.